Ajoutez une description, des images, des menus et des liens à votre méga-menu
Une colonne sans paramètres peut être utilisée comme un espaceur
Lien vers vos collections, vos ventes et même des liens externes
Ajoutez jusqu'à cinq colonnes
Ajoutez une description, des images, des menus et des liens à votre méga-menu
Une colonne sans paramètres peut être utilisée comme un espaceur
Lien vers vos collections, vos ventes et même des liens externes
Ajoutez jusqu'à cinq colonnes
octobre 29, 2016 2 lire la lecture
Every once and a while we need to get back to basics. Yes, we need to focus on the day of birth because of the high incidence of maternal and newborn mortality that occurs on this critical day.
But what insidious factors are at play and underlie problems on the day of birth? What causes that day of birth to occur TOO EARLY IN THE PREGNANCY? What if a certain sexually transmitted disease was easy to detect and easy to treat?
According to the World Health Organization (WHO), each year more than 2 million pregnant women are diagnosed with active syphilis (Treponema pallidum), 65% of which result in adverse pregnancy outcomes: fetal death in early to late gestation (fetal death and stillbirth) or neonatal death soon after birth.
Surviving children diagnosed with congenital syphilis (mother to child transmission) are often born with low birth weight and develop serious problems, such as blindness, deafness, and cognitive impairment. Studies have shown that early intervention by testing and appropriate treatment with penicillin, can eradicate syphilis with a success rate of 98%.
Despite the threat of contracting syphilis in some countries being high, up to one third of the women attending antenatal care (ANC) clinics are not tested for syphilis during pregnancy check-ups. Research shows women who have access to antenatal care in the first two trimesters of their pregnancy and who receive the proper care and follow up, are more likely to have a healthy infant, compared to women screened and treated in the third trimester; making it imperative that effective intervention and care be available early in pregnancy.
Syphilis testing and treatment are relatively inexpensive even in low-resource settings, compared with other interventions, with tests typically costing less than $1 US, and treatment (often a single dose of penicillin) less than that. The magnitude of the congenital syphilis burden, globally, cannot be underestimated; it rivals that of HIV infection in neonates yet receives little attention.
It has been estimated that untreated syphilis in pregnancy can directly cause adverse outcomes in around 50% of cases. In comparison, HIV, if untreated, will result in in-utero transmission around 20%. Syphilis is an entirely treatable disease, however, left untreated, it puts an already at-risk population in even more uncertain circumstances. Paramount to the success of syphilis detection and treatment is the coordination of government policy with health care systems, building awareness, and their respective agencies, who provide screenings and treatment, so that proper antenatal care can lead to healthier mother and child outcomes.
Credit: The research for this post and the post were contributed by Isolde Maher, intern from Mt. Holyoke
1. http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001396(Accessed 5/31/13)
2. ibid(Accessed 5/31/13)
3. http://www.cdc.gov/std/syphilis/STDFact-Syphilis-detailed.htm (Accessed 6/1/13)
4. http://www.who.int/bulletin/volumes/91/3/12-107623/en/index.html (Accessed 6/1/13)
5. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0056713 (Accessed 6/1/13)
6.http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001396#s4
7.http://journals.lww.com/stdjournal/Abstract/2007/07001/The_Need_and_Plan_for_Global_Elimination_of.3.aspx (Accessed 5/31/13)
8. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0056713(Accessed 6/1/13)
Les commentaires sont approuvés avant leur publication.
juin 30, 2026 13 lire la lecture
mai 25, 2026 1 lire la lecture
Des vêtements antichoc non-pneumatiques (NASG) de haute qualité, conformes à la norme ISO 13485 et marqués CE, produits par Maternova pour être utilisés par les sages-femmes et les obstétriciens du monde entier afin de sauver des vies menacées par l'hémorragie post-partum. Nos NASG respectent les normes les plus strictes et sont approuvés par des centaines de cliniciens.
mai 25, 2026 3 lire la lecture
L'USPSTF, l'ACOG, la Society for Maternal-Fetal Medicine et la FIGO recommandent toutes l'aspirine à faible dose (LDA) pour les grossesses à haut risque. Les obstacles sont systémiques, comportementaux et structurels.
Inscrivez-vous pour recevoir les dernières actualités sur les soldes, les nouveautés et bien plus encore...